STAT Plus: Pfizer, with early however hopeful outcomes, leaps into the race for a Duchenne gene remedy

An experimental Pfizer (PFE) gene remedy seems to assist youngsters with Duchenne muscular dystrophy, a deadly muscle-wasting illness that impacts as many as 12,000 American boys, in keeping with a small however intently watched examine that shall be introduced Friday.

Two of the six boys who had been handled with the gene remedy for a yr or extra carried out higher on a take a look at of muscle operate, however its unwanted side effects had been extreme sufficient that two different boys had been hospitalized.

Unlock this text by subscribing to STAT Plus and luxuriate in your first 30 days free!


What’s it?

STAT Plus is a premium subscription that delivers day by day market-moving biopharma protection and in-depth science reporting from a crew with many years of trade expertise.

What’s included?

Authoritative biopharma protection and evaluation, interviews with trade pioneers, coverage evaluation, and first appears at innovative laboratories and early stage analysis
Subscriber-only networking occasions and panel discussions throughout the nation
Month-to-month subscriber-only dwell chats with our reporters and consultants within the area
Discounted tickets to trade occasions and early-bird entry to trade experiences